Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation
- PMID: 12062613
- DOI: 10.1016/s0360-3016(02)02785-2
Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation
Abstract
Purpose: To determine whether excision of an in-breast tumor recurrence (IBTR) plus 5000 cGy in 25 fractions to the new operative area is both tolerated and effective as treatment for an IBTR after previous lumpectomy and whole breast irradiation.
Methods and materials: Thirty-nine women with an IBTR after lumpectomy and breast irradiation for invasive carcinoma (n = 31) or ductal carcinoma in situ (n = 8) were treated with excision of the IBTR and radiotherapy (RT), 5000 cGy in 25 fractions, to the operative area using electrons of appropriate energy. The interval from completion of the first course of RT to diagnosis of the IBTR ranged from 16 to 291 months (median 63).
Results: The repeat course of RT to the new operative area was well tolerated in all patients, and no late sequelae occurred other than skin pigmentation changes. Eight patients, including 2 with suspicious bone scans at the time of IBTR, developed distant metastases, and 7 died 21-71 months (median 48) after retreatment. One patient was alive with distant metastases at 27 months after retreatment. Four of the 8 patients who developed distant metastases also had a second IBTR, and 3 died with persistent disease in the breast. An additional 4 patients, for a total of 8, had a second IBTR. Three were alive and free of disease after mastectomy, and 1 was alive and free of disease after mastectomy and additional RT for chest wall recurrence. An additional patient developed recurrence in the axilla 9 months after reirradiation and was treated with surgery; she died free of disease at 63 months. One patient underwent mastectomy for suspected persistent disease 2 months after completion of repeat RT; no evidence of recurrent tumor was found in the removed breast. Thus, 30 women (76.9%) had an intact breast free of tumor at death or at last follow-up 1-180 months (median 51.5) after reirradiation. Using the Kaplan-Meier life table analysis, the estimated overall and disease-free 5-year survival rate for the 39 patients was 77.9% and 68.5%, respectively.
Conclusion: For select patients with an IBTR after lumpectomy and breast irradiation, excision of the IBTR followed by repeat external beam RT to the operative area may be an acceptable alternative to mastectomy.
Similar articles
-
Salvage radiotherapy for local failures of lumpectomy and breast irradiation.Radiother Oncol. 1997 Jan;42(1):25-9. doi: 10.1016/s0167-8140(96)01864-6. Radiother Oncol. 1997. PMID: 9132822
-
Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.Eur J Surg Oncol. 2016 Apr;42(4):474-80. doi: 10.1016/j.ejso.2016.01.011. Epub 2016 Jan 22. Eur J Surg Oncol. 2016. PMID: 26853760
-
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11. Int J Radiat Oncol Biol Phys. 2005. PMID: 16005576
-
Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.Eur J Surg Oncol. 2019 Aug;45(8):1317-1327. doi: 10.1016/j.ejso.2019.02.008. Epub 2019 Feb 10. Eur J Surg Oncol. 2019. PMID: 30795956
-
Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings.Semin Surg Oncol. 1992 May-Jun;8(3):153-60. Semin Surg Oncol. 1992. PMID: 1496226 Review.
Cited by
-
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes.Rep Pract Oncol Radiother. 2017 Jul-Aug;22(4):277-283. doi: 10.1016/j.rpor.2017.02.009. Epub 2017 May 5. Rep Pract Oncol Radiother. 2017. PMID: 28507456 Free PMC article.
-
Breast conserving surgery versus salvage mastectomy for ipsilateral breast cancer recurrence: a propensity score matching analysis.Updates Surg. 2022 Apr;74(2):479-489. doi: 10.1007/s13304-021-01122-3. Epub 2021 Jun 28. Updates Surg. 2022. Retraction in: Updates Surg. 2022 Oct;74(5):1795. doi: 10.1007/s13304-022-01342-1. PMID: 34181187 Retracted.
-
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study.J Contemp Brachytherapy. 2020 Jun;12(3):207-215. doi: 10.5114/jcb.2020.96860. Epub 2020 Jun 30. J Contemp Brachytherapy. 2020. PMID: 32695191 Free PMC article.
-
A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.Ann Surg Oncol. 2022 Oct;29(10):6440-6453. doi: 10.1245/s10434-022-12197-6. Epub 2022 Jul 18. Ann Surg Oncol. 2022. PMID: 35849299
-
Radical Radiation Therapy for Radiation-Induced Angiosarcoma with Local Control.Case Rep Oncol. 2021 Dec 13;14(3):1779-1784. doi: 10.1159/000519596. eCollection 2021 Sep-Dec. Case Rep Oncol. 2021. PMID: 35082640 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical